X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3722) 3722
Publication (419) 419
Book Review (26) 26
Newsletter (15) 15
Book Chapter (10) 10
Conference Proceeding (10) 10
Dissertation (7) 7
Newspaper Article (5) 5
Reference (3) 3
Book / eBook (2) 2
Data Set (1) 1
Magazine Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2126) 2126
magnetic resonance imaging (1880) 1880
index medicus (1851) 1851
radiology, nuclear medicine & medical imaging (1794) 1794
animals (1603) 1603
gadolinium (1508) 1508
magnetic resonance imaging - methods (1478) 1478
female (1447) 1447
male (1411) 1411
contrast media - pharmacokinetics (1295) 1295
contrast media (1240) 1240
gadolinium dtpa - pharmacokinetics (867) 867
middle aged (843) 843
gadolinium dtpa (775) 775
adult (738) 738
mri (684) 684
aged (639) 639
mice (639) 639
rats (632) 632
contrast agents (582) 582
gadolinium - pharmacokinetics (512) 512
sensitivity and specificity (508) 508
contrast media - administration & dosage (492) 492
image enhancement - methods (485) 485
cancer (453) 453
reproducibility of results (435) 435
organometallic compounds - pharmacokinetics (417) 417
gd-dtpa (383) 383
contrast agent (372) 372
contrast media - chemistry (361) 361
pharmacokinetics (354) 354
tissue distribution (352) 352
liver (335) 335
tumors (335) 335
medicine & public health (311) 311
article (301) 301
gadolinium - chemistry (300) 300
in-vivo (291) 291
gadolinium dtpa - administration & dosage (286) 286
nanoparticles (286) 286
nephrogenic systemic fibrosis (276) 276
permeability (272) 272
kernspintomographie (271) 271
perfusion (264) 264
time factors (259) 259
gd-eob-dtpa (255) 255
nuclear magnetic resonance--nmr (255) 255
diagnosis (253) 253
imaging / radiology (245) 245
image interpretation, computer-assisted - methods (229) 229
aged, 80 and over (227) 227
oncology (216) 216
radiology (215) 215
rats, sprague-dawley (206) 206
pharmacology & pharmacy (202) 202
contrast media - adverse effects (200) 200
dce-mri (200) 200
brain (197) 197
cell line, tumor (196) 196
safety (194) 194
models, biological (186) 186
retrospective studies (186) 186
image processing, computer-assisted (184) 184
chemistry, multidisciplinary (183) 183
kontrastmittel (183) 183
research (180) 180
algorithms (179) 179
angiogenesis (175) 175
organometallic compounds (175) 175
computer simulation (174) 174
organometallic compounds - administration & dosage (174) 174
pentetic acid - pharmacokinetics (174) 174
ultrasound (171) 171
image enhancement (168) 168
tumor (167) 167
pentetic acid - analogs & derivatives (166) 166
diagnostic radiology (165) 165
injections, intravenous (165) 165
rabbits (162) 162
gadolinium - administration & dosage (160) 160
disease models, animal (159) 159
usage (159) 159
medicine (157) 157
magnetic-resonance (155) 155
mice, nude (155) 155
lesions (154) 154
adolescent (150) 150
gadopentetate dimeglumine (148) 148
liver - metabolism (148) 148
neuroradiology (148) 148
therapy (148) 148
gadolinium - adverse effects (147) 147
relaxivity (143) 143
kinetics (142) 142
medical imaging (141) 141
angiography (140) 140
gadolinium dtpa - chemistry (140) 140
rats, wistar (140) 140
model (138) 138
fibrosis (137) 137
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3694) 3694
German (35) 35
Japanese (9) 9
Chinese (8) 8
French (8) 8
Italian (5) 5
Portuguese (3) 3
Spanish (3) 3
Korean (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 2009, Volume 136, Issue 1, pp. 14 - 20
Journal Article
Investigative Radiology, ISSN 0020-9996, 2017, Volume 52, Issue 6, pp. 317 - 323
For magnetic resonance, the established class of intravenous contrast media is the gadolinium-based contrast agents. In the 3 decades since initial approval,... 
Gadodiamide | Gadobenate dimeglumine | Gadoversetamide | Magnetic resonance | Gadolinium | Gadolinium-based contrast agents | Safety | Dentate nucleus | Gadopentetate dimeglumine | Contrast media | magnetic resonance | HIGH-SIGNAL INTENSITY | gadolinium-based contrast agents | gadoversetamide | T1 HYPERINTENSITY | GLOBUS-PALLIDUS | RENAL-FUNCTION | HEALTHY RATS | TAP WATER | dentate nucleus | gadodiamide | T1-WEIGHTED MR-IMAGES | gadopentetate dimeglumine | safety | contrast media | ANIMAL-MODELS | gadobenate dimeglumine | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | gadolinium | Injections, Intravenous | Gadolinium - pharmacokinetics | Humans | Contrast Media - pharmacokinetics | Muscle, Skeletal - metabolism | Bone and Bones - drug effects | Brain - metabolism | Contrast Media - adverse effects | Bone and Bones - metabolism | Muscle, Skeletal - drug effects | Gadolinium DTPA - pharmacokinetics | Marketing - legislation & jurisprudence | Meglumine - adverse effects | Gadolinium DTPA - adverse effects | Risk Assessment | Organometallic Compounds - adverse effects | Europe | Organometallic Compounds - pharmacokinetics | Gadolinium - adverse effects | Pharmacovigilance | Meglumine - analogs & derivatives | Brain - drug effects | Magnetic Resonance Imaging | Animals | Meglumine - pharmacokinetics | Practice Guidelines as Topic
Journal Article
Journal Article
European Radiology, ISSN 0938-7994, 3/2012, Volume 22, Issue 3, pp. 642 - 653
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 03/2015, Volume 202, pp. 21 - 30
The main goal of this study was to assess the theranostic performance of a nanomedicine able to generate MRI contrast as a response to the release from... 
MOLECULAR IMAGING APPLICATIONS | MILD HYPERTHERMIA | THERAPY | TARGETED DRUG-DELIVERY | SOLID TUMORS | CONTRAST AGENTS | PARAMAGNETIC LIPOSOMES | NANOMEDICINE | THERMOSENSITIVE LIPOSOMES | PHARMACOLOGY & PHARMACY | TEMPERATURE-SENSITIVE LIPOSOMES | CHEMISTRY, MULTIDISCIPLINARY | Gadolinium - administration & dosage | Doxorubicin - therapeutic use | Gadolinium - pharmacokinetics | Contrast Media - pharmacokinetics | Doxorubicin - chemistry | Mammary Neoplasms, Experimental - metabolism | Antibiotics, Antineoplastic - chemistry | Contrast Media - administration & dosage | Mammary Neoplasms, Experimental - pathology | Ultrasonography | Female | Antibiotics, Antineoplastic - pharmacokinetics | Doxorubicin - administration & dosage | Mammary Neoplasms, Experimental - drug therapy | Heterocyclic Compounds - administration & dosage | Organometallic Compounds - pharmacokinetics | Mammary Neoplasms, Experimental - diagnostic imaging | Doxorubicin - pharmacokinetics | Antibiotics, Antineoplastic - administration & dosage | Magnetic Resonance Imaging | Animals | Antibiotics, Antineoplastic - therapeutic use | Tumor Burden - drug effects | Cell Line, Tumor | Heterocyclic Compounds - pharmacokinetics | Mice, Inbred BALB C | Liposomes | Organometallic Compounds - administration & dosage | Chemotherapy | Anthracyclines | Magnetic resonance imaging | Cancer
Journal Article